![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/4184 | (2006.01) |
A61P 35/00 | (2006.01) | ||
C07D 403/04 | (2006.01) |
(11) | Number of the document | 2722046 |
(13) | Kind of document | T |
(96) | European patent application number | 14151089.1 |
Date of filing the European patent application | 2008-10-10 | |
(97) | Date of publication of the European application | 2014-04-23 |
(45) | Date of publication and mention of the grant of the patent | 2016-12-21 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
979643 P | 2007-10-12 | US |
(72) |
Kolaczkowski, Lawrence, US
|
(73) |
AbbVie Ireland Unlimited Company,
70 Sir John Rogerson`s Quay, Dublin 2,
IE
|
(54) | 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1 |
2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1 |